HIF1A and breast carcinoma: EGC reduced LDHA activity in breast cancer (MCF-7 and MDA-MB-231) cell lines; notably, LDHA inhibition results from the dissociation of HSP90 from HIF-1α, resulting in HIF-1α proteasomal degradation.